Close
Back to SNSS Stock Lookup

Sunesis Pharmaceuticals (SNSS) – Litigation

Feb 16, 2021 08:02 AM Viracta Therapeutics Announces Notice of Allowance for U.S. Patent Application Covering the Use of its Combination Product Candidate for the Treatment of Epstein-Barr Virus-associated Lymphoma (SNSS)

Back to SNSS Stock Lookup